Vanguard Asset Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.59M Buy
77,892
+4,796
+7% +$231K ﹤0.01% 1240
2026
Q2
$4.29M Buy
73,096
+4,228
+6% +$177K ﹤0.01% 1132
2026
Q1
$2.22M Buy
+68,868
New +$2.55M ﹤0.01% 1407

Other funds holding VCYT

Vanguard Asset Management's VCYT Position: Q3 2026 in Review

Vanguard Asset Management increased its Veracyte (VCYT) stake by 6.6% in Q3 2026, buying an estimated $231K and bringing the position to 77,892 shares worth $3.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

Vanguard Asset Management first reported a position in VCYT in Q1 2026 and has held it in 3 quarters since. The position peaked at $4.29M in Q2 2026. 300 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Vanguard Asset Management held 77,892 shares of Veracyte worth $3.59M as of Q3 2026.
  • Vanguard Asset Management bought 4,796 Veracyte shares in Q3 2026, an estimated $231K.
  • Veracyte made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #1240 holding.
  • Vanguard Asset Management first reported a position in Veracyte in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's Veracyte position peaked at $4.29M in Q2 2026.
  • 300 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.